SLC6A1 and epilepsy: Dysfunction or mutations in SLC6A1 have been linked to neurodevelopmental disorders, in which disrupted GABAergic signaling is associated with developmental delays, epilepsy, autism spectrum disorders, and motor dysfunction [30].